Although some argue that generating central memory T cells should be the goal of vaccination against Mtb [73,74], we and others argue that generating resident effector memory cells may be more important [3,75–77], as CD8+ T cells residing at the site of infection may be poised to initiate an earlier response. The gene discussed is CD8A; the disease is infection.